DOCS Stock Cash Flow Statements

Doximity Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Doximity Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30

cash flows from operating activities
net income	53,320,000	62,458,000	75,196,000	44,154,000	41,377,000	40,618,000	47,956,000	30,602,000	28,406,000	30,668,000	33,468,000	26,299,000	22,383,000	36,726,000	55,647,000	36,088,000	26,322,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	2,794,000	2,829,000	2,655,000	2,613,000	2,562,000	2,548,000	2,509,000	2,604,000	2,604,000	2,708,000	2,616,000	2,589,000	2,370,000	1,368,000	1,361,000	1,158,000	1,153,000
stock-based compensation, net of amounts capitalized	21,865,000	18,060,000	19,368,000	17,868,000	17,090,000	11,857,000	11,771,000	13,447,000	14,001,000	12,991,000	13,984,000	11,353,000	9,506,000	9,809,000	9,834,000	6,672,000	5,127,000
non-cash lease expense	450,000	446,000	441,000	470,000	481,000	475,000	522,000	540,000	537,000	537,000	538,000	551,000	401,000	302,000	288,000	286,000	283,000
accretion of discount on marketable securities	-2,488,000		-3,368,000	-3,008,000	-2,360,000
amortization of deferred contract costs	3,896,000	3,423,000	1,785,000	2,033,000	2,726,000	2,593,000	1,548,000	2,063,000	2,667,000	2,428,000	1,518,000	2,072,000	2,767,000	2,389,000	1,710,000	2,452,000	3,204,000
other	-408,000	-19,000	411,000	616,000	-738,000	773,000	472,000	137,000	-152,000	657,000	790,000	37,000	-30,000	-160,000	640,000
changes in operating assets and liabilities:
accounts receivable	-13,381,000	9,258,000	-12,986,000	-4,106,000	-19,372,000	-4,516,000	-1,135,000	-4,388,000	14,032,000	-32,433,000	3,997,000	-3,339,000	5,533,000	-11,438,000	-14,023,000	-9,977,000	4,421,000
prepaid expenses and other assets	-4,234,000	-18,489,000	1,303,000	9,488,000	10,460,000	-16,502,000	6,523,000	-13,093,000	2,589,000	-5,372,000	-1,727,000	2,405,000	1,246,000	-2,086,000	11,188,000	-14,870,000	-3,321,000
deferred contract costs	-1,965,000	-2,982,000	-5,853,000	-1,785,000	-1,431,000	-1,683,000	-4,477,000	-1,238,000	-1,210,000	-2,053,000	-4,067,000	-1,476,000	-866,000	-2,937,000	-3,697,000	-1,483,000	-1,492,000
accounts payable, accrued expenses and other liabilities	-165,000	-4,535,000	9,418,000	7,396,000	-12,942,000	5,966,000	10,429,000	-8,740,000	677,000	-2,918,000	7,197,000	1,635,000	-6,109,000
deferred revenue	2,973,000	45,295,000	-24,628,000	-9,161,000	3,704,000	32,496,000	-24,823,000	-6,831,000	-6,922,000	35,625,000	-19,970,000	-4,280,000	6,152,000	19,366,000	-12,775,000	-4,197,000	-566,000
operating lease liabilities	-556,000	-550,000	-545,000	-538,000	-516,000	-510,000	-586,000	-579,000	-3,000	-4,000	2,000	-13,000	-198,000	-296,000	-173,000	-167,000	-471,000
net cash from operating activities	62,101,000	98,487,000	65,189,000	68,346,000	41,243,000	63,944,000	50,054,000	12,898,000	57,200,000	46,639,000	48,697,000	39,514,000	44,752,000	46,964,000	27,284,000	19,152,000	33,175,000
capex	0	0	0	0	0	0	-36,000	-41,000	-70,000	-21,000	-27,000	-592,000	-436,000	-1,060,000	-1,500,000	-1,020,000	-751,000
free cash flows	62,101,000	98,487,000	65,189,000	68,346,000	41,243,000	63,944,000	50,018,000	12,857,000	57,130,000	46,618,000	48,670,000	38,922,000	44,316,000	45,904,000	25,784,000	18,132,000	32,424,000
cash flows from investing activities
internal-use software development costs	-1,966,000	-1,507,000	-1,771,000	-1,543,000	-1,704,000	-1,634,000	-1,288,000	-1,238,000	-1,494,000	-1,005,000	-1,012,000	-1,051,000	-1,415,000
purchases of marketable securities	-139,934,000	-143,724,000	-164,025,000	-197,395,000	-170,413,000	-191,529,000	-101,112,000	-144,942,000	-35,284,000	-60,303,000	-39,080,000	-82,307,000	-8,870,000	-45,278,000	-115,772,000	-1,088,768,000	-67,375,000
maturities of marketable securities	144,579,000	118,180,000	99,308,000	215,855,000	202,058,000	116,993,000	105,418,000	96,119,000	116,649,000	48,125,000	10,576,000	16,167,000	8,271,000	6,302,000	6,066,000	24,787,000	10,764,000
net cash from investing activities	2,679,000	-24,473,000	-58,924,000	24,158,000	29,941,000	-76,170,000	40,132,000	-50,102,000	117,326,000	-13,204,000	13,304,000	-18,523,000	-41,500,000	-23,626,000	-25,520,000	-534,005,000	-57,423,000
cash flows from financing activities
proceeds from issuance of common stock upon exercise of stock options and common stock warrants	2,398,000	5,827,000	3,662,000			3,134,000	2,540,000	3,933,000	3,285,000	2,471,000	1,871,000	2,570,000	3,014,000
taxes paid related to net share settlement of equity awards	-11,927,000	-10,856,000	-8,107,000	-5,828,000	-2,394,000	-1,424,000	-1,248,000	-2,120,000	-1,964,000	-1,469,000	-1,092,000	-1,152,000	-109,000	-381,000	-380,000
repurchase of common stock	-122,355,000	-26,788,000	-19,307,000	-22,984,000	-51,214,000	-17,740,000	-76,792,000	-164,429,000	-21,755,000	-15,282,000	0	-61,168,000	-8,874,000	0	0
payment of contingent consideration related to a business combination	-5,249,000	0	0	0	-5,470,000	0	0	0	-5,390,000
net cash from financing activities	-137,133,000	-29,670,000	-25,243,000	-19,698,000	-56,527,000	-14,078,000	-75,500,000	-161,122,000	-25,824,000	-11,862,000	779,000	-57,409,000	-5,969,000	4,392,000	3,794,000	53,000	552,176,000
net increase in cash and cash equivalents	-72,353,000	44,344,000	-18,978,000	72,806,000	14,657,000	-26,304,000			148,702,000	21,573,000	62,780,000	-36,418,000	-2,717,000	27,730,000	5,558,000	-514,800,000	527,928,000
cash and cash equivalents, beginning of period	209,614,000	0	0	0	96,785,000	0	0	0	158,027,000	0	0	0	112,809,000	0	0	0	66,393,000
cash and cash equivalents, end of period	137,261,000	44,344,000	-18,978,000	72,806,000	111,442,000	-26,304,000	14,686,000	-198,326,000	306,729,000	21,573,000	62,780,000	-36,418,000	110,092,000	27,730,000	5,558,000	-514,800,000	594,321,000
supplemental disclosures of cash flow information
cash paid for taxes, net of refunds	4,978,000	19,840,000	13,829,000	9,078,000	12,907,000		8,925,000
non-cash financing and investing activities
share repurchases included in accrued expenses				-898,000	1,002,000
excise tax payable on share repurchases	745,000			-220,000	1,713,000		571,000
deferred income taxes		-13,788,000	1,992,000							3,834,000	9,287,000	0	105,000	-9,275,000
amortization of premium (accretion of discount) on marketable securities						-1,761,000	-1,683,000	-1,495,000	-299,000
impairment of long-lived assets		0	0
changes in operating assets and liabilities, net of effect of acquisition:
cash paid for acquisition											0	0	-53,500,000
purchases of property and equipment						0	-36,000	-41,000	-70,000	-21,000	-204,000	-766,000	-710,000	-1,060,000	-611,000	-200,000	-41,000
sales of marketable securities		2,578,000	7,564,000			0	37,150,000	0	37,525,000	0	43,024,000	49,434,000	14,724,000	16,864,000	85,862,000
proceeds from issuance of common stock in connection with the employee stock purchase plan		2,147,000	0			1,952,000	0			2,418,000	0
payment of excise taxes on share repurchases		0
fair value of contingent earn-out consideration included in purchase consideration
operating lease right-of-use assets obtained in exchange for operating lease liabilities											0	3,882,000	10,877,000
repurchase included in accrued expenses
capitalized stock-based compensation for internal-use software development costs											177,000	174,000	274,000		176,000	80,000	61,000
net income on sale of marketable securities
change in fair value of contingent earn-out consideration liability					202,000	183,000
proceeds from issuance of common stock upon exercise of stock options					2,551,000									3,378,000	4,174,000	2,323,000	2,737,000
proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions														0	0	0	553,905,000
payments of deferred offering costs															0	-2,214,000	-1,768,000
loss on sale and redemption of marketable securities							260,000
net decrease in cash and cash equivalents
loss on sale of marketable securities									273,000	0			37,000
cash paid for taxes											2,381,000				2,000	49,000	131,000
amortization of premium on marketable securities										-29,000	471,000	1,218,000	1,455,000		1,302,000	1,264,000	297,000
gain on sale of business
cash paid for acquisition, net of cash acquired
proceeds from sale of business
conversion of redeemable convertible preferred stock to common stock															0	0	81,458,000
gain on sale of marketable securities
property and equipment included in accounts payable and accrued expenses												-523,000	632,000			63,000	71,000
adjustments to reconcile net income to net cash from operating activities
unpaid deferred offering costs																	2,214,000
payments for deferred offering costs
proceeds from exercise of redeemable convertible preferred stock warrants
bad debt expense															-120,000	288,000	-93,000
accounts payable															454,000	-421,000	129,000
accrued expenses and other current liabilities
other liabilities															2,000	-60,000	-9,000
capitalized internal-use software															-1,065,000	-900,000	-771,000
common stock issued in acquisition
amounts held in escrow related to sale of business
receivable from exercise of stock options included in prepaid expenses and other current assets															75,000	-293,000	298,000
operating lease right-of-use assets obtained in exchange for modified operating lease liabilities
amortization of prepaid partner fees																231,000	568,000
accrued expenses																1,958,000	-2,377,000
common stock issued in exchange for services
repurchase and retirement of common stock																	-2,698,000

We provide you with 20 years of cash flow statements for Doximity stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Doximity stock. Explore the full financial landscape of Doximity stock with our expertly curated income statements.

The information provided in this report about Doximity stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.